Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 268-629-5 | CAS number: 68131-75-9 A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately -51°C to -1°C (-60°F to 30°F.)
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-GLP, non-guideline animal and human experimental studies, reported in peer reviewed literature, notable restrictions in design (human data only) but otherwise adequate for assessment.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 000
Materials and methods
- Objective of study:
- toxicokinetics
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Closed chamber uptake studies in mice & rats. 1 human exposed using a mask. PBPK model developed.
- GLP compliance:
- no
Test material
- Reference substance name:
- Propene
- EC Number:
- 204-062-1
- EC Name:
- Propene
- Cas Number:
- 115-07-1
- Molecular formula:
- C3H6
- IUPAC Name:
- prop-1-ene
- Details on test material:
- Propene, purity >99.9% ex Messer Greisheim (Krefield, Germany).
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- other: Mice, rats, human
- Strain:
- other: NMRI and B6C3F1 mice, Sprague-Dawley and Fischer 344/N rats
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- - Male NMRI mice (30-45 g) and male Sprague-Dawley rats (300-500 g), were obtained from the breeding facility of GSF (Neuherberg, Germany).
- Male B6C3F1 mice (20-30 g) and male Fischer 344/N rats (210-290 g) were purchased from Charles River Wiga (Sulzfeld, Germany).
- Animals were fed with standard chow Nr 1324 from Altromin (Lage, Germany), had free access to tap water, and were maintained until experiments on a 12-h light/dark cycle in climate-controlled air (23°C, 60% relative humidity).
- A 48 year old male volunteer, 95 kg was exposed.
Administration / exposure
- Route of administration:
- inhalation
- Vehicle:
- other: air
- Details on exposure:
- - Mice and rats: closed chamber technique, whole body exposure, 2 rats or 5 mice/chamber.
- All glass chambers, 6.6 L volume (except for DDC pre-treated mice, 0.8 L).
- Exhaled CO2 trapped by soda lime and the chamber air was replenished automatically with the equivalent amount of O2. Chamber temperature was 19 -24ºC.
- Human exposure to constant propene concentrations via a two-valve breathing mask. - Duration and frequency of treatment / exposure:
- Rats and mice: single, up to >24hr.
Human: single, up to 265 min.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
Exposure of mice and rats to varying propene concentrations: initial concentrations of 10 - 10500ppm (17-18100 mg/m3) propene.
Exposure of rats to constant propene concentrations: concentrations of propene were 20.3, 62, 104, 253, 373, 496, 1000, 2020, 3000ppm (35-5200 mg/m3)
Human exposed to constant concentrations of 5 or 25ppm (9 or 43 mg/m3).
- No. of animals per sex per dose / concentration:
- 2 rats or 5 mice per chamber. Human exposure (n=1).
- Control animals:
- no
- Details on study design:
- Liquid:air and tissue:air partition coefficients were determined in vitro using water and olive oil (liquid) and blood, kidney, liver, brain, lung, fat, and muscle of mouse, rat, and human. Tissues were obtained from NMRI mice, Sprague-Dawley rats and human blood from a volunteer, human tissue from an autopsy. Propene was analysed by gas chromatography.
Exposure of rats and mice to varying concentrations of propene: Usually, naive animals were exposed. Some animals were pre-treated with sodium diethyldithiocarbamate (DDC) in 0.9% saline solution (50 mg DDC/mL) in order to inhibit cytochrome P450-dependent metabolism. DDC was administered 0.5 to 6 h before exposure. Mice received DDC doses of 400 mg/kg and rats received doses of 200 mg/kg. - Statistics:
- Toxicokinetic analysis: A physiological toxicokinetic model was used to simulate the inhalation of propene vapour, its distribution by the blood flow into several compartments, the metabolism, and the exhalation of the unchanged compound.
Results and discussion
- Preliminary studies:
- Tissue:air partition coefficients for propene measured in-vitro indicate a very low potential for accumulation in tissues; values for adipose were approximately 10x other tissues. The blood:air partition coefficient for propene for human tissue is approximately half that in rodents probably due to species differences in lipophilicity of haemoglobin.
Main ADME resultsopen allclose all
- Type:
- absorption
- Results:
- uptake of propene by inhalation is controlled by the air concentration, the blood:air partition coefficient and the perfusion rate of the lung and at high concentrations by saturable metabolism
- Type:
- distribution
- Results:
- predicted steady state concentrations of propene in human tissues are approximately twice those in rodents for the same blood concentration
- Type:
- excretion
- Results:
- elimination is via metabolism and exhalation of unchanged propene, for concentrations below saturation of metabolism, predicted percentage of the inhaled dose exhaled unchanged is 86%, 92% and 93% for mouse, rat and human respectively
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Uptake of propene by inhalation is controlled by the air concentration, the blood:air partition coefficient and the perfusion rate of the lung and at high concentrations by saturable metabolism.
- Details on distribution in tissues:
- Predicted steady state concentrations of propene in human tissues are approximately twice those in rodents for the same blood concentration
- Details on excretion:
- Elimination of propene is via metabolism and exhalation of unchanged propene. For exposures below the concentration at which metabolism becomes saturated, the predicted percentage of the inhaled dose exhaled unchanged is 86%, 92% and 93% for mouse, rat and human respectively.
Toxicokinetic parametersopen allclose all
- Toxicokinetic parameters:
- other: mouse: Vmax=110 µmol/h/kg; Km=270 ppm
- Toxicokinetic parameters:
- other: rat: Vmax=50.4 µmol/h/kg; Km=400 ppm
Metabolite characterisation studies
- Metabolites identified:
- no
- Details on metabolites:
- The ability of sodium diethyldithiocarbamate (DDC) to inhibit propene metabolism indicates that most propene metabolism is oxidative.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: no bioaccumulation potential based on study results
Uptake of propene by inhalation is controlled by diffusion kinetics and cardiac output. Species differences in the blood:air partition coefficient for propene (human approximately half rodent) are probably due to differences in lipophilicity of haemoglobin. Tissue:air partition coefficients for propene measured in-vitro indicate a very low potential for accumulation in tissues. Propene metabolism is predominantly oxidative. Elimination of propene is via metabolism and exhalation of unchanged propene. The maximum rates of metabolism (Vmax) of propene were 110 and 50.4 µmol/h/kg for mouse and rat, respectively; Km was 270 and 400 ppm in mice and rats, respectively. For exposures below the concentration at which metabolism becomes saturated, the predicted percentage of the inhaled dose exhaled unchanged is >86% in both rodents and humans. - Executive summary:
In this study, male NMRI mice, male B6C3F1 mice, male Sprague-Dawley rats and male Fischer rats as well as one male human volunteer were exposed to propene in order to develop a PBPK model. Mice and rats were exposed in a closed chamber, wholy body technique, while human exposure was performed using two-valve breathing mask.The initial exposure propene contrantration for mice and rats were 10 - 10500ppm (17-18100 mg/m3). The exposure of rats to constant propene concentrations were as follows: 20.3, 62, 104, 253, 373, 496, 1000, 2020, 3000ppm (35-5200 mg/m3); while human volunteer was exposed to constant concentrations of 5 or 25ppm (9 or 43 mg/m3). Liquid:air and tissue:air partition coefficients were determined in vitro using water and olive oil (liquid) and myltiple tissues obtained from NMRI mice, Sprague-Dawley rats, human blood from a volunteer and human tissue from an autopsy. The results showed that propene has no bioaccumulation potential based on this study.
Uptake of propene by inhalation is controlled by diffusion kinetics and cardiac output. Tissue:air partition coefficients for propene measured in-vitro indicate a very low potential for accumulation in tissues. Propene metabolism is predominantly oxidative. Elimination of propene is via metabolism and exhalation of unchanged propene. The maximum rates of metabolism (Vmax) of propene were 110 and 50.4 µmol/h/kg for mouse and rat, respectively; Km was 270 and 400 ppm in mice and rats, respectively. For exposures below the concentration at which metabolism becomes saturated, the predicted percentage of the inhaled dose exhaled unchanged is >86% in both rodents and humans.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.